Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2022 Q2
15 of 19 quarters
Total Value
$34.84M
Total Shares
2.53M
Net Share Change
+399.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$34.84M
2.53M
0.9%
ADD
+399.2K
(+18.7%)
Maverick Capital
$34.84M
2.53M shares
ADD
+399.2K
(+18.7%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy